Concepedia

Toshito Nakagawa

TN

Statistics

Publications

13

Citations

246

H-Index

11

Active since

1989

Affiliations

Chugai Pharma (United States)(Current)

Roche (Switzerland)

Roche (United States)

The University of Osaka

Osaka University of Pharmaceutical Sciences

Toshito Nakagawa is an author at Chugai Pharma (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1989–2023

13

Publications

13

5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity

Pascale David Pierson, Alec Fettes, Christian Freichel et al. · Journal of Medicinal Chemistry · 2009 · 33 citations · Full text

, , +17

Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist

Yoshikazu Nishimura, Toru Esaki, Yoshiaki Isshiki et al. · Journal of Medicinal Chemistry · 2020 · 28 citations · Full text

, , +13

Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure-Activity Relationships of Its Derivatives

Kazutaka Tachibana, Ikuhiro Imaoka, Takuya Shiraishi et al. · Chemical and Pharmaceutical Bulletin · 2008 · 24 citations · Full text

, , +17

Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells

Shun Nakai, Ima Shibata, Takahiro Shitamichi et al. · Biology Open · 2019 · 23 citations · Full text

, , +17

Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer

Hitoshi Yoshino, Haruhiko Sato, Takuya Shiraishi et al. · Bioorganic & Medicinal Chemistry · 2010 · 21 citations · Full text

, , +14

1–5 of 13